Related Experiment Video
Updated: Aug 29, 2025

Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations
Published on: November 7, 2019
Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2
Gang Xu1, Yezi Wu1, Tongyang Xiao1
1Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, 518112, Shenzhen, Guangdong Province, China.
Abstract:
The Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a global pandemic that seriously threatens health and socioeconomic development, but the existed antiviral drugs and vaccines still cannot yet halt the spread of the epidemic. Therefore, a comprehensive and profound understanding of the pathogenesis of SARS-CoV-2 is urgently needed to explore effective therapeutic targets. Here, we conducted a multiomics study of SARS-CoV-2-infected lung epithelial cells, including transcriptomic, proteomic, and ubiquitinomic. Multiomics analysis showed that SARS-CoV-2-infected lung epithelial cells activated strong innate immune response, including interferon and inflammatory responses. Ubiquitinomic further reveals the underlying mechanism of SARS-CoV-2 disrupting the host innate immune response. In addition, SARS-CoV-2 proteins were found to be ubiquitinated during infection despite the fact that SARS-CoV-2 itself didn't code any E3 ligase, and that ubiquitination at three sites on the Spike protein could significantly enhance viral infection. Further screening of the E3 ubiquitin ligases and deubiquitinating enzymes (DUBs) library revealed four E3 ligases influencing SARS-CoV-2 infection, thus providing several new antiviral targets. This multiomics combined with high-throughput screening study reveals that SARS-CoV-2 not only modulates innate immunity, but also promotes viral infection, by hijacking ubiquitination-specific processes, highlighting potential antiviral and anti-inflammation targets.
Insights
This study reveals how SARS-CoV-2 hijacks host ubiquitination processes to disrupt innate immunity and enhance viral infection. Identifying specific E3 ligases offers potential new antiviral and anti-inflammation targets for COVID-19 treatment.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- COVID-19 pandemic caused by SARS-CoV-2 poses significant global health and socioeconomic challenges.
- Existing antiviral drugs and vaccines are insufficient to fully control SARS-CoV-2 spread.
- Understanding SARS-CoV-2 pathogenesis is crucial for identifying effective therapeutic targets.
Purpose of the Study:
- To investigate the pathogenesis of SARS-CoV-2 in lung epithelial cells using a multiomics approach.
- To elucidate the role of ubiquitination in SARS-CoV-2 infection and host immune response modulation.
- To identify novel antiviral and anti-inflammation targets by screening E3 ligases and DUBs.
Main Methods:
- Multiomics analysis including transcriptomics, proteomics, and ubiquitinomics of SARS-CoV-2-infected lung epithelial cells.
- Investigation of ubiquitination of SARS-CoV-2 proteins, particularly the Spike protein.
- High-throughput screening of E3 ubiquitin ligase and deubiquitinating enzyme libraries.
Main Results:
- SARS-CoV-2 infection activates strong innate immune responses, including interferon and inflammatory pathways.
- Ubiquitinomics revealed SARS-CoV-2 hijacks host ubiquitination processes to disrupt innate immunity.
- Ubiquitination of the Spike protein enhances viral infection; four E3 ligases were identified as influencing SARS-CoV-2 infection.
Conclusions:
- SARS-CoV-2 modulates host innate immunity and promotes viral infection by manipulating ubiquitination pathways.
- Targeting specific ubiquitination processes and identified E3 ligases presents potential antiviral and anti-inflammatory strategies against COVID-19.
More Related Videos
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Regulation of the Unfolded Protein Response
Genomics
The Unfolded Protein Response

